ITMCTR2100004280招募中4 期
Clinical study of Shenshao tablet on improving exercise tolerance of patients with chronic ischemic heart failure (qi deficiency and blood stasis syndrome)
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 35 至 74(—)
- 性别
- All
入选标准
- •1. According to the diagnostic criteria of chronic ischemic heart failure, refer to Chinese guidelines for the diagnosis and treatment of heart failure 2018:
- •(1)Previous history of myocardial infarction; coronary angiography or CT angiography showed at least one major coronary artery branch stenosis > 50%.
- •(2)LVEF < 50% or with symptoms / signs of heart failure.
- •(3)Coronary artery disease is closely related to heart failure.
- •2. In accordance with the diagnostic criteria of qi deficiency and blood stasis syndrome, refer to the technical guidelines for clinical research of new traditional Chinese medicine in chronic heart failure:
- •(1)Main symptoms: shortness of breath / wheezing, fatigue, palpitation.
- •(2)Secondary symptoms: a.languid and lazy speech, easy to work; b. spontaneous sweating; c.low voice; d.dark complexion / lips.
- •(3)Tongue vein: the tongue is dark (or with ecchymosis, ecchymosis or tortuous purplish vein under the tongue), the moss is thin and white, and the pulse is heavy, thin, astringent or ineffectual.
- •3. New York Heart Association (NYHA) cardiac function class II - IV;
- •4. The age ranged from 35 to 74 years;
- •5. Informed consent, volunteers.
排除标准
- •1. Patients with chronic heart failure who need medical treatment in the near future;
- •2. Patients complicated with acute coronary syndrome (within 30 days), cardiogenic shock, acute myocarditis, hypertension (systolic blood pressure >= 180mmhg and / or diastolic blood pressure >= 110mmhg), malignant arrhythmia, hypertrophic obstructive cardiomyopathy, severe valvular disease requiring surgical treatment and pulmonary embolism, etc.;
- •3. Severe hepatic and renal insufficiency;
- •4. Severe anemia;
- •5. Psychopath;
- •6. Cancer patients;
- •7. Patients participating in drug clinical trials in recent months;
- •8. Pregnant or lactating women.
研究者
相似试验
Unknown
4 期
Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina PectorisCoronary Heart DiseaseStable AnginaNCT04270279Guang'anmen Hospital of China Academy of Chinese Medical Sciences120
已完成
4 期
Influence of Shenqu Xiaoshi Oral Liquid on Intestinal Microbiome of Children With Functional DyspepsiaChildDyspepsiaNCT05515887Ruijin Hospital50
尚未招募
4 期
clinical efficacy of Shengxuening tablets for cancer anemia:a randomized, double-blind studyITMCTR2100004715Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
尚未招募
4 期
Clinical trial of Zhen Shu Tiu Zhi Capsule in treating diabetic damp heat syndrome and study on biological basis of damp heat syndrome of glycolipid metabolic diseasesDiabetesITMCTR2200005519Dongzhimen Hospital, Beijing University of Chinese Medicine
招募中
4 期
Intervention of compound Xueshuantong Capsule on the incidence of heart failure in patients with acute myocardial infarction after PCI based on the combination of disease and syndromeAcute myocardial infarctionITMCTR1900002665The First Affiliated Hospital of Guangzhou University of Chinese Medicine
